Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 20;9:675. doi: 10.3389/fneur.2018.00675

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Chen, Wu, Wang and Luo.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The results of episodic memory in the patients with anti-NMDAR encephalitis and health controls (HCs). (A) The patients showed marginally significant verbal episodic memory impairments at T1, and no obvious damage at T2 and T3 during the recovery period. (B) The patients showed significant or marginally significant non-verbal episodic memory impairments at T1 and T2, and no obvious damage at T3 during the recovery period. CAVLT, Chinese version of verbal learning test. AFLT, Aggie figures learning test. T1 = 1 to 2 months following initial immunotherapy. T2 = 6 months following initial immunotherapy. T3 = 11 to 12 months following initial immunotherapy. The two-sample t-test between the patients and health controls (HCs) at three time points. **p < 0.05/3; *p < 0.1/3 (Bonferroni correction).